On August 15, 2025, the U.S. Court of Appeals for the D.C. Circuit limited FDA's ability to deny a hearing on the approvability of a new drug application (NDA) based on a lack of “substantial evidence ...
In a unanimous decision, the Supreme Court held in Axon v. FTC that the FTC Act (and the SEC Act) do not prohibit a federal court from hearing challenges to the constitutionality of either ...
It’s a good bet that when one party to a lawsuit wants a case remanded to an administrative agency, it’s the defendant. That’s because one of the primary effects of a remand is delay. But defendants ...
Justice Clarence Thomas sent a warning shot across the bow of the expansive administrative state in a recent opinion suggesting it was time the court upend the litany of agencies that act as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results